Marshall Wace’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.8M Sell
376,242
-158,861
-30% -$10M 0.03% 472
2025
Q1
$28.3M Sell
535,103
-157,700
-23% -$8.35M 0.04% 391
2024
Q4
$38.8M Buy
692,803
+286,188
+70% +$16M 0.05% 320
2024
Q3
$21.3M Buy
406,615
+299,806
+281% +$15.7M 0.03% 446
2024
Q2
$4.39M Buy
106,809
+87,059
+441% +$3.57M 0.01% 952
2024
Q1
$856K Buy
+19,750
New +$856K ﹤0.01% 1498
2023
Q4
Sell
-34,494
Closed -$791K 2234
2023
Q3
$791K Sell
34,494
-1,877
-5% -$43K ﹤0.01% 1325
2023
Q2
$600K Sell
36,371
-57,475
-61% -$948K ﹤0.01% 1529
2023
Q1
$1.67M Buy
93,846
+72,563
+341% +$1.29M ﹤0.01% 1228
2022
Q4
$620K Buy
+21,283
New +$620K ﹤0.01% 1749
2021
Q2
Sell
-178,757
Closed -$3.8M 2484
2021
Q1
$3.8M Buy
178,757
+159,599
+833% +$3.39M 0.02% 890
2020
Q4
$570K Sell
19,158
-9,034
-32% -$269K ﹤0.01% 1284
2020
Q3
$611K Buy
28,192
+17,935
+175% +$389K ﹤0.01% 1141
2020
Q2
$229K Buy
+10,257
New +$229K ﹤0.01% 1358
2019
Q4
Sell
-2,298
Closed -$50K 1957
2019
Q3
$50K Buy
+2,298
New +$50K ﹤0.01% 1447
2019
Q2
Sell
-14,715
Closed -$403K 1730
2019
Q1
$403K Buy
14,715
+12,417
+540% +$340K ﹤0.01% 1188
2018
Q4
$62K Buy
+2,298
New +$62K ﹤0.01% 1422